Eating behavior and adherence in obese adult subjects treated carlo
Carlo
Maurizio
to dietary prescriptions with 5-hydroxytryptophan1’2
Maria Del Ben, Alessandro Laviano,
Rossi-Fanelli adin obese subjects (14). The present study attempted to confirm
Cangiano,
Muscaritoli,
Fabrizio
Ceci,
Fabiola
Antonia
Antonucci, have (5-HTP) food data adherence 20 obese
Cascino,
and shownintake, over
Filippo that and oral
ABSTRACT
ministration prescriptions of causes
Previous
anorexia,
observations
decreased these
5-hydroxytryptophan To confirm
without a longer
dietary weight period
these data over whether adherence administering
a longer period of observation to dietary restriction could to obese hyperphagic
and to verify be improved by
loss inobese
ofobservation tion could
subjects.
5-HTP
subjects.
and to verify whether be improved by 5-HTP,
to dietary restricpatients were ran-
domly assigned to receive either 5-HTP (900 mg/d) or a placebo. The study was double-blinded and was for two consecutive 6-wk periods. No diet was prescribed during the first period, a 5040kJ/d diet was recommended in 5-HTP-treated for thesecond. patients Significant during both weight periods.
Subjects
Subjects
and methods
Downloaded from www.ajcn.org by on September 26, 2008
Twenty-eight
obese,
hyperphagic
adult
female
subjects
(mean 30 and of daily
loss was observed
A reduction in carbohydrate intake and a consistent presence of early satiety were also found. These findings together with the goodtolerance observed suggest that 5-HTP may be safely used to treat KEY obesity. WORDS
age 43.2 y ± I .7: SE) with 40 were studied. Hyperphagia
body mass indexes between was defined as the excess
energy introduced with respect according to sex, age, and physical intolerance, from the hyperlipidemia, study. or
to the energy need calculated activity. Subjects with glucose hyperuricemia wereexcluded
Am J Clin Nutr
Eating obesity, loss behavior, adherence
1992;56:863-7. anorexia, to diet, 5-hydroxytrypappetite for car-
tophan, serotonin, bohydrates, weight
Study The
design research ofthe consent, protocol University subjects was approved by the Faculty Ethics
Introduction
Pharmacological, accumulated rotonin has animals possible genesis this idea and role (5-7).biochemical, and behavioral evidence brain both has sein
Committee informed
of Rome, La Sapienza. were randomly assigned or a placebo composed stearate (both from The drug, which was
After giving to receive
either 5-HTP (900 mg/d) mannitol, and magnesium dustries, capsules per day, subdivided wk periods. tions, during whereas the second Pomezia, Italy).
ofcorn starch, Sigma-Tau Ininthe form of
in the last an inhibitory
two decades, suggesting that influence on eating behavior studies system diseases
in humans ( I -4). Reported played by the serotoninergic present Changes in different in the different deprivation metabolism nutritional producing
in favor of a in the pathofurther support serotonin
that do not dissolve until pH 8.6, was taken three times 30 mmbefore each meal. The 12-wk-study period was for each group of subjects into two consecutive 6During the first period period diet there was were The no dietary 5040 restricsuba 5040-kJ/d recommended to subjects U were
ofanorexia
of brain
in animals experiencing reported (8, 9). Food in serotonin changes stitutes metabolism
states have been a marked increase may reflect in turnconresponses
ofobservation.
in the lateral
hypothalamus
divided as follows: 53% from carbohydrates, and 18% from proteins. No carbohydrate-rich between meals. Subjects were examined every feeding behavior and body measurements were performed weight. Routine for each subject
29% from lipids, foods were allowed 2 wk to evaluate blood chemistry at the beginning
in the availability ofbrain...
Regístrate para leer el documento completo.